Yes... but it's not unique or a game changer in the cognition/ cortisol lowering market. At present the hype is based to its association with Alzheimer's... there are no studies as yet to suggest it will be effective at preventing or slowing down brain atrophy. To make these claims will take many years of additional reasearch and clinical trials. Question is, if you are investing as opposed to trading, how long are you willing to wait until a product is ready for market (assuming one will ever make it to market)... 5 years... 10 years... Let's see
Ann: Cognitive improvement demonstrated with Xanamem, page-111
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
0.001(3.57%) |
Mkt cap ! $73.28M | |||
| Open | High | Low | Value | Volume |
| 2.8¢ | 2.9¢ | 2.7¢ | $55.10K | 1.986M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 200000 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 103736 | 2 |
View Market Depth
| Last trade - 16.10pm 14/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.9¢ |
Change
0.001 ( 3.57 %) |
||||
| Open | High | Low | Volume | ||
| 2.8¢ | 2.9¢ | 2.7¢ | 871276 | ||
| Last updated 15.59pm 14/05/2024 ? | |||||
| ACW (ASX) Chart |